compare glp 1 Comparing GLP-1 Medications for Diabetes and Obesity | Shima Ahmed posted on the topic GLP-1R Agonists for Weight Loss

Metformin, the current first-line treatment in T2DM, has an unclear antidepressant effect [166] despite identified direct mechanisms and pleiotropic effects, including inhibition of angiotensin II and NF-B factor, normalization of gut microbiota, and intestinal permeabilization, and in vivo experimental data [167] supporting its potential benefits

Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease

doi: 10.1016/J.OPHTHA.2014.05.013/ATTACHMENT/4DFFCC6A-BE96-4720-96C7-1DA6395D6ECE/MMC5.PDF 75 CuiQNSteinLMFortinSMHayesMR

Early data from amycretin showed up to 13.1% weight loss in just 36 weeks of a phase 1/2 trial, with the weight loss curve still descending steeply

Under a moderate-cost scenario, increases range from 1.0 percent to 3.0 percent, depending on eligibility and adherence

I., Nouh, M